Cleveland BioLabs, Inc. (Nasdaq:CBLI) is a clinical-stage biotechnology company with a focus on oncology and orphan drug development. Since our inception in 2003, we have pursued the research, development and commercialization of proprietary products that have the potential to treat cancer, prevent and treat acute radiation syndrome and counteract the toxic effects of radio and chemotherapies for oncology patients. Presently, we have nine product candidates in our pipeline that are being developed directly by us and our majority-owned subsidiaries, Incuron, LLC and Panacela Labs, Inc.
View Top Employees from Cleveland Biolabs| Website | http://www.cbiolabs.com |
| Ticker | CBLI |
| Revenue | $1 million |
| Funding | $53.4 million |
| Employees | 21 (20 on RocketReach) |
| Founded | 2003 |
| Address | 73 High St, Buffalo, New York 14203, US |
| Phone | (716) 849-6810 |
| Fax | (716) 849-6820 |
| Technologies |
JavaScript,
HTML,
PHP
+27 more
(view full list)
|
| Industry | Biotechnology Research, Drug Manufacturing & Research, Biotechnology, Oncology, Pharmaceuticals, Science and Engineering, Radiation Countermeasure, Healthcare, Health Care, Orphan Drugs, Medical |
| Web Rank | 20 Million |
| Keywords | Cleveland Biolabs, Entolimod Cleveland Biolabs Patent |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 54 Companies |
Looking for a particular Cleveland Biolabs employee's phone or email?
Cleveland Biolabs Questions
The Cleveland Biolabs annual revenue was $1 million in 2024.
Vadim Krivokrysenko is the Vice President of Preclinical Development of Cleveland Biolabs.
20 people are employed at Cleveland Biolabs.
Cleveland Biolabs is based in Buffalo, New York.
The NAICS codes for Cleveland Biolabs are [32541, 541, 5417, 3254, 325, 32, 54].
The SIC codes for Cleveland Biolabs are [28, 283].
Top Cleveland Biolabs Employees
-
View
Vadim Krivokrysenko
Vice President of Preclinical Development at Cleveland Biolabs
New York, United States23 -
11
-
25
-
33
-
21
-
12
-
21
Related Companies
